Medical Providers
The Effectiveness of Electronic Screening and Brief Intervention for Reducing Levels of Alcohol Consumption: A Systematic Review and Meta-Analysis
EHR Modification
The 10 Building Blocks of High-Performing Primary Care
Developing and Running a Primary Care Practice Facilitation Program: A How-To Guide
Alcohol and Drug Use Disorders
Module 2: Changing Language To Change Care: Stigma and Substance Use Disorder
Discusses the importance of language when discussing substance use and reviews ways to improve language used during clinical encounters to improve patient care
Module 4: Pharmacotherapy for Alcohol Use Disorder
Describes and compares pharmacological treatment options for individuals with AUD, including FDA- approved medications acamprosate, disufiram, and naltrexone, as well as two other evidence-based treatments that are not yet FDA approved, topiramate and gabapentin; includes diagnosis of AUD, definitions of binge drinking and “at risk” drinking, and a case vignette; up to 1 AMA PRA Category 1 Credit™ for continuing education
Module 10: Mutual-Help and Related Clinical Interventions
Describes 12-step programs and how providers can help their patients get to and best use these programs, including patients taking medications for substance use disorder; up to 1 AMA PRA Category 1 Credit (TM) for continuing education
Efficacy and Safety of Naltrexone and Acamprosate in the Treatment of Alcohol Dependence: A Systematic Review
Pagination
- Previous page
- Page 67
- Next page